Regulatory Briefs: Draft Guidances On Hearing Aids, Syphilis Tests; Upcoming Panel Meetings
This article was originally published in The Gray Sheet
Executive Summary
FDA issues draft guidance clarifying the difference between hearing aid devices and personal sound amplification products. Agency also issues draft guidance on the use of tests to screen human cells and tissues for syphilis. Boston Sci gets a new panel date for Watchman. More regulatory news.
You may also be interested in...
Industry, Consumers Seek Greater Clarity In Hearing Aid Draft Guidance
Companies and consumer groups asked FDA for a clearer distinction between hearing aid devices and personal sound amplification products in recent comments submitted in response to an FDA draft guidance.
Regulatory News In Brief
Agency issues proposed orders to reclassify intra-aortic balloon and control systems, tuberculosis IVDs and stair-climbing wheelchairs. Industry mainly supports FDA’s communications draft guidance. More regulatory news.
PROTECT AF Results Show Long-Term Efficacy Of Watchman LAA Closure Device
Boston Scientific is highlighting a secondary-endpoint analysis showing that the left-atrial appendage closure device reduced all-cause death by 34 percent. The company plans to submit a PMA for the device by the end of the second quarter.